Chronic Cholestatic Liver Injury Attributable to Vedolizumab

Jonathan Stine, J Wang, BW Behm

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)277-280
JournalJournal of Clinical and Translational Hepatology
Volume4
Issue number3
StatePublished - Sep 28 2016

Cite this

@article{a37e3b9ac19248f7a0a4198fa5beb99f,
title = "Chronic Cholestatic Liver Injury Attributable to Vedolizumab",
author = "Jonathan Stine and J Wang and BW Behm",
year = "2016",
month = "9",
day = "28",
language = "English (US)",
volume = "4",
pages = "277--280",
journal = "Journal of Clinical and Translational Hepatology",
number = "3",

}

Chronic Cholestatic Liver Injury Attributable to Vedolizumab. / Stine, Jonathan; Wang, J; Behm, BW.

In: Journal of Clinical and Translational Hepatology, Vol. 4, No. 3, 28.09.2016, p. 277-280.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic Cholestatic Liver Injury Attributable to Vedolizumab

AU - Stine, Jonathan

AU - Wang, J

AU - Behm, BW

PY - 2016/9/28

Y1 - 2016/9/28

M3 - Article

VL - 4

SP - 277

EP - 280

JO - Journal of Clinical and Translational Hepatology

JF - Journal of Clinical and Translational Hepatology

IS - 3

ER -